Pittenger & Anderson Inc Astrazeneca PLC Transaction History
Pittenger & Anderson Inc
- $2.54 Billion
- Q2 2025
A detailed history of Pittenger & Anderson Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Pittenger & Anderson Inc holds 51,245 shares of AZN stock, worth $3.77 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
51,245
Previous 60,606
15.45%
Holding current value
$3.77 Million
Previous $4.45 Million
19.6%
% of portfolio
0.14%
Previous 0.19%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
508MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...